PL372924A1 - Łączne zastosowanie L-karnityny, acetylo L-karnityny i propionylo L-karnityny do leczenia oligoasthenoteratospermii - Google Patents

Łączne zastosowanie L-karnityny, acetylo L-karnityny i propionylo L-karnityny do leczenia oligoasthenoteratospermii

Info

Publication number
PL372924A1
PL372924A1 PL03372924A PL37292403A PL372924A1 PL 372924 A1 PL372924 A1 PL 372924A1 PL 03372924 A PL03372924 A PL 03372924A PL 37292403 A PL37292403 A PL 37292403A PL 372924 A1 PL372924 A1 PL 372924A1
Authority
PL
Poland
Prior art keywords
carnitine
propionyl
acetyl
oligoasthenoteratospermia
treatment
Prior art date
Application number
PL03372924A
Other languages
English (en)
Other versions
PL214859B1 (pl
Inventor
Giorgio Cavallini
Giulio Biagiotti
Aleardo Koverech
Francesca Sardelli
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of PL372924A1 publication Critical patent/PL372924A1/pl
Publication of PL214859B1 publication Critical patent/PL214859B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL372924A 2002-04-09 2003-04-08 Laczne zastosowanie L-karnityny, acetylo L-karnityny i propionylo L-karnityny do leczenia oligoastenoteratospermii PL214859B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002RM000194A ITRM20020194A1 (it) 2002-04-09 2002-04-09 Composizione utile per aumentare la concentrazione e la motilita' degli spermatozoi e migliorarne la morfologia nell'uomo.

Publications (2)

Publication Number Publication Date
PL372924A1 true PL372924A1 (pl) 2005-08-08
PL214859B1 PL214859B1 (pl) 2013-09-30

Family

ID=11456235

Family Applications (1)

Application Number Title Priority Date Filing Date
PL372924A PL214859B1 (pl) 2002-04-09 2003-04-08 Laczne zastosowanie L-karnityny, acetylo L-karnityny i propionylo L-karnityny do leczenia oligoastenoteratospermii

Country Status (19)

Country Link
US (2) US20050107470A1 (pl)
EP (1) EP1492521B1 (pl)
JP (1) JP4663987B2 (pl)
KR (1) KR20040098005A (pl)
CN (1) CN1330301C (pl)
AT (1) ATE476974T1 (pl)
AU (1) AU2003224443B2 (pl)
BR (1) BR0309055A (pl)
CA (1) CA2478674C (pl)
CY (1) CY1111273T1 (pl)
DE (1) DE60333742D1 (pl)
DK (1) DK1492521T3 (pl)
ES (1) ES2350338T3 (pl)
IT (1) ITRM20020194A1 (pl)
MX (1) MXPA04009763A (pl)
PL (1) PL214859B1 (pl)
PT (1) PT1492521E (pl)
SI (1) SI1492521T1 (pl)
WO (1) WO2003084526A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776913B2 (en) 2002-12-13 2010-08-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Carnitines for treating or preventing disorders caused by andropause
US8377454B2 (en) * 2009-05-01 2013-02-19 Parviz Gharagozloo Treating male infertility secondary to sperm oxidative stress
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
CN108041588A (zh) * 2017-12-08 2018-05-18 冯纪敏 一种含有海藻糖的组合物及其应用
CN109999042B (zh) * 2019-05-16 2021-05-18 北京华睿鼎信科技有限公司 包含脱氢表雄酮或其硫酸酯、左卡尼汀、乙酰左卡尼汀或它们的可药用盐的组合物及其应用
CN118435893B (zh) * 2024-05-17 2025-12-19 北部湾大学 L-乙酰肉碱提升香港牡蛎繁殖性能的方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1249462B (it) * 1991-10-21 1995-02-23 Sigma Tau Ind Farmaceuti Impiego di l-carnitina e acil l-carnitine nel trattamento delle oligoastenospermie idiopatiche.
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
IT1295408B1 (it) * 1997-10-03 1999-05-12 Sigma Tau Ind Farmaceuti Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo
GB9721746D0 (en) 1997-10-15 1997-12-10 Panos Therapeutics Limited Compositions
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
ITRM20010029A1 (it) * 2001-01-23 2002-07-23 Aldo Fassi Sali metallici di carnitine utili come integratori dietetici/nutrizionali o come farmaci, composizioni che li contengono e procedimenti per
ITRM20020055A1 (it) 2002-02-04 2003-08-04 Aldo Fassi Sali metallici di carnitine, integratori dietetici/nutritivi che li contengono e kit dietetici per contrastare disturbi sessuali in soggetti

Also Published As

Publication number Publication date
US8415392B2 (en) 2013-04-09
JP2006505499A (ja) 2006-02-16
PL214859B1 (pl) 2013-09-30
ES2350338T3 (es) 2011-01-21
DE60333742D1 (de) 2010-09-23
BR0309055A (pt) 2005-02-22
WO2003084526A1 (en) 2003-10-16
CA2478674A1 (en) 2003-10-16
CN1330301C (zh) 2007-08-08
JP4663987B2 (ja) 2011-04-06
KR20040098005A (ko) 2004-11-18
ATE476974T1 (de) 2010-08-15
CN1638754A (zh) 2005-07-13
EP1492521B1 (en) 2010-08-11
HK1078460A1 (en) 2006-03-17
PT1492521E (pt) 2010-11-11
SI1492521T1 (sl) 2010-12-31
DK1492521T3 (da) 2010-11-22
ITRM20020194A1 (it) 2003-10-09
MXPA04009763A (es) 2004-12-13
AU2003224443A1 (en) 2003-10-20
CY1111273T1 (el) 2015-08-05
ITRM20020194A0 (it) 2002-04-09
EP1492521A1 (en) 2005-01-05
US20050107470A1 (en) 2005-05-19
AU2003224443B2 (en) 2008-09-11
US20090012169A1 (en) 2009-01-08
CA2478674C (en) 2010-10-19

Similar Documents

Publication Publication Date Title
EA200800006A1 (ru) Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i
TW200507830A (en) Bronchodilating β -agonist compositions and methods
BR0313282A (pt) Composições de inibidor seletivo de ciclooxigenase-2 e um inibidor de anidrase carbÈnica para o tratamento de neoplasia
IS7814A (is) Fenetanólamín afleiða í meðhöndlun á öndunarfærasjúkdómum.
WO2003088748A8 (en) Use of heme oxygenase-1 and products of heme degradation
MXPA05010000A (es) Derivados de p-diaminobenceno substituidos.
WO2005004808A3 (en) TETRACYCLIC COMPOUNDS AS c-MET INHIBITORS
TW200621765A (en) Substituted phenylaminothiazoles and their use
ATE357438T1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
WO2003082268A3 (en) Hemiasterlin derivatives and uses thereof in the treatment of cancer
PL1919466T3 (pl) Formulacje do leczenia nieprawidłowości lipoproteinowych obejmujące statynę i pochodną metylonikotynoamidu
IL151146A0 (en) Process and device for the treatment of water, particularly for ships
SI1492521T1 (sl) Kombinirana uporaba l-karnitina, acetil l-karnitina in propil l-karnitina za zdravljenje oligoastenoteratospermije
GB0215526D0 (en) Anticancer compounds
AU2003296724A1 (en) Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders
MXPA05006408A (es) Derivados deuterizados de catecolamina y medicamentos comprendiendo estos compuestos.
MY136288A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
TR200200224T2 (tr) Böbrek bozukluğu ve hastalıklarının önlenmesi ve tedavisi için bileşim
MXPA04011018A (es) Nueva combinacion de inhibidores reversibles de la bomba de protones y productos terapueticos para tratar trastornos de las vias respiratorias.
UA85187C2 (en) 2-aminobenzoyl derivatives
DK1569635T3 (da) Anvendelse af carnitiner til forebyggelse og/eller behandling af lidelser forårsaget af andropause
GB0119810D0 (en) Prophylactic and therapeutic uses of hydroxysteroids
AU2003253558A1 (en) Naphthamide derivatives and their use
MY136638A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
MXPA05007253A (es) Sales novedosas de derivados anticonvulsivantes.